Medicine and Dentistry
Left Ventricular Assist Device
100%
Sildenafil
100%
Vascular Remodeling
100%
Adverse Event
40%
Apoplexy
30%
Fibrosis
30%
Congestive Heart Failure
30%
Bleeding
20%
Angiodysplasia
20%
Arterial Stiffness
20%
Endothelial Dysfunction
20%
Phosphodiesterase
20%
Placebo
20%
Device Therapy
20%
Diabetes Mellitus
10%
Angiopoietin 2
10%
Pulmonary Hypertension
10%
Platelet
10%
Capsule Endoscopy
10%
Endothelin 1
10%
Vascular Tissue
10%
Smooth Muscle Cell
10%
Thrombocyte Activation
10%
High-Risk Population
10%
Brain Ischemia
10%
Antithrombotic
10%
Patient Experience
10%
Capillary
10%
Survival Rate
10%
Messenger RNA
10%
Finger
10%
Population
5%
Keyphrases
Vascular Remodeling
50%
Left Ventricular Assist Device Support
50%
Sildenafil
50%
Left Ventricular Assist Device
21%
Bleeding
14%
Fibrosis
14%
Endothelial Dysfunction
14%
Angiodysplasia
14%
Phosphodiesterase
14%
Antifibrotic
14%
Left Ventricular Assist Device Therapy
14%
Heart Failure
14%
Adverse Events
14%
Small Vessels
14%
Pulsatility
14%
Vascular Adverse Events
14%
Differential mRNA Expression
14%
Longitudinal Change
7%
Video Capsule Endoscopy
7%
Arterial Stiffness
7%
Large Vessel
7%
Platelet Activation
7%
Between-group Difference
7%
Vascular Tissue
7%
Small Blood Vessels
7%
Improved Outcomes
7%
Placebo
7%
Pharmaceutics
7%
Ischemic Stroke
7%
Improved Survival
7%
Acute Decompensated Heart Failure
7%
Adverse Event Rates
7%
Survival Rate
7%
Durable Left Ventricular Assist Device
7%
Vasculogenic
7%
Type 1 Diabetes Mellitus (T1DM)
7%
Hypertension
7%
Vascular Aging
7%
Endothelin-1 (ET-1)
7%
Low Platelet Count
7%
High-risk Population
7%
Platelets
7%
United States
7%
Device Placement
7%
Pulmonary Hypertension
7%
Angiopoietin-2
7%
Carotid Distensibility
7%
Randomized Placebo-controlled Trial
7%
Smooth muscle Cells
7%
Thrombotic
7%
Device Design
7%
Avascular Necrosis
7%
Patient Experience
7%
Aortic Stiffness
7%
Pharmacology, Toxicology and Pharmaceutical Science
Sildenafil
50%
Vascular Remodeling
50%
Adverse Event
28%
Cerebrovascular Accident
21%
Congestive Heart Failure
21%
Fibrosis
14%
Angiodysplasia
14%
Phosphodiesterase
14%
Endothelial Dysfunction
14%
Placebo
14%
Bleeding
14%
Vascular Fibrosis
14%
Brain Ischemia
7%
Angiopoietin 2
7%
Survival Rate
7%
Anticoagulant Agent
7%
Endothelin 1
7%
Messenger RNA
7%
Diabetes Mellitus
7%
Pulmonary Hypertension
7%